Eli Lilly (LLY) Stock News Today: Orforglipron Pill Data, Pricing Moves, and Wall Street Forecasts for 2026
December 18, 2025 — Eli Lilly and Company (NYSE: LLY) is back in the spotlight after the drugmaker released new Phase 3 results for its experimental oral obesity medicine orforglipron, a development investors have been watching closely as the weight-loss market pushes beyond injections and into pills. At the same time, a report said Lilly is preparing material price cuts in Canada for its blockbuster medicines Mounjaro and Zepbound—a reminder that pricing and access remain central to the long-term investment case. Reuters+2Reuters+2 Eli Lilly stock price today LLY shares were trading around $1,060 on Thursday, December 18, up about 1.75%